Track the Canadian Junior Mining Market at the speed of AI

Build a portfolio of Canadian junior mining companies on 6ix and get real-time updates the minute they announce something. Discover investor events, company profiles, and news in one place.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
Just now	Adyton Resources Announces Filing of Financial Statements and MD&A for the Three Months Ending March 31, 2026
Just now	BluMetric Announces Q2 2026 Financial Results
Just now	ComEd Renewable Energy Investments Help Expand Customer Access to Clean Energy and Lower Costs
Just now	Avis Budget Group Announces Pricing of $300 Million of Senior Notes
Just now	NexMetals Announces Results of Annual General Meeting of Shareholders

About

9.10USD-0.28 -2.99%

Closed • Updated at 21:38 GMT+00:00

Market Cap$1.53B

Volume1.39M

Beta1.03

RSI45.28

Gross Margin82.21%

Health TechnologyBiotechnology

Vir Biotechnology, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Vir Biotechnology to Present Complete Week 96 Data from Phase 2 SOLSTICE Clinical Trial in Hepatitis Delta at the European Association for the Study of the Liver (EASL) Congress 2026

Sotrovimab (Xevudy: Vir Biotechnology, GlaxoSmithKline) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Vir Biotechnology Provides Corporate Update and Reports First Quarter 2026 Financial Results

Vir Biotechnology to Participate in Bank of America Securities 2026 Healthcare Conference

Vir Biotechnology to Host Conference Call for First Quarter 2026 Financial Results

Recent Videos

Vir Biotechnology: Marianne De Backer on Immuno-Oncology, Hepatitis Delta, and Biotech Turnarounds

Vir Biotechnology: Marianne De Backer on Immuno-Oncology, Hepatitis Delta, and Biotech Turnarounds

Apr 27, 2026

Vir Biotechnology Inc. 2025 annual report

Vir Biotechnology Inc. 2025 annual report

Mar 06, 2026

Vir Bio's Cancer Treatment Progress Driving Shares Hight | Bloomberg Businessweek

Vir Bio's Cancer Treatment Progress Driving Shares Hight | Bloomberg Businessweek

Mar 02, 2026

UPWARD MOMENTUM | VIR STOCK ANALYSIS | VIR BIOTECHNOLOGY STOCK

UPWARD MOMENTUM | VIR STOCK ANALYSIS | VIR BIOTECHNOLOGY STOCK

Feb 26, 2026

Community Chat

Ask AI

Try asking